Valuation: Gedeon Richter

Market Cap 2,211B 7.08B 6.22B 5.73B 5.34B 10.07B 674B 10.26B 68.79B 26.67B 331B 26.57B 25.98B 1,150B P/E 2026 *
8.47x
P/E 2027 * 7.77x
Enterprise Value 1,896B 6.07B 5.34B 4.91B 4.58B 8.63B 578B 8.8B 59B 22.88B 284B 22.79B 22.29B 986B EV / Sales 2026 *
1.99x
EV / Sales 2027 * 1.75x
Free-Float
72.87%
Yield 2026 *
5.12%
Yield 2027 * 5.48%
1 week+1.00%
Current month+0.59%
1 month-3.54%
3 months+9.99%
6 months+32.18%
Current year+32.18%
1 week 33.54
Extreme 33.54
34.94
1 month 32.5
Extreme 32.5
35.9
Manager TitleAgeSince
Chief Executive Officer 47 31/10/2017
Director of Finance/CFO - 30/04/2025
Chief Operating Officer - 31/12/2018
Director TitleAgeSince
Chairman 78 31/12/2016
Chairman 90 29/02/2024
Director/Board Member 65 25/04/2012
Change 5-day change 1-year change 3-year change Capi.($)
+0.59%+0.83%+38.02% - 7.05B
+0.20%-0.10%+11.37%+77.46% 47.26B
-1.30%-0.42%+49.14%+102.33% 35B
-0.59%+1.65%-3.27%+43.52% 12.52B
-0.31%-0.27%+12.05%+90.24% 11.74B
-1.38%-2.72%+29.46%+115.95% 8.67B
-0.84%+1.67%+51.89%-9.13% 6.9B
-1.92%-0.80%+23.27%+219.81% 6.58B
+7.24%+10.32%-27.74%+9.65% 5.23B
-2.20%+5.02%+30.05%+126.31% 4.52B
Average -0.12%+2.26%+21.42%+86.24% 15.38B
Weighted average by Cap. -0.36%+0.93%+23.26%+85.65%

Financials

2026 *2027 *
Net sales 952B 3.05B 2.68B 2.46B 2.3B 4.33B 290B 4.42B 29.62B 11.48B 143B 11.44B 11.19B 495B 1,024B 3.28B 2.88B 2.65B 2.47B 4.66B 312B 4.75B 31.85B 12.35B 153B 12.3B 12.03B 532B
Net income 259B 831M 730M 672M 626M 1.18B 79.13B 1.2B 8.07B 3.13B 38.85B 3.12B 3.05B 135B 286B 916M 805M 741M 691M 1.3B 87.26B 1.33B 8.9B 3.45B 42.85B 3.44B 3.36B 149B
Net Debt -315B -1.01B -885M -815M -759M -1.43B -95.94B -1.46B -9.79B -3.8B -47.11B -3.78B -3.7B -164B -421B -1.35B -1.19B -1.09B -1.02B -1.92B -129B -1.96B -13.11B -5.08B -63.1B -5.06B -4.95B -219B
Logo Gedeon Richter
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Employees
-
Date Price Change
01/07/26 €34.34 +0.59%
30/06/26 €34.14 -0.47%
29/06/26 €34.30 -0.23%
26/06/26 €34.38 +0.29%
25/06/26 €34.28 +0.82%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
12,120.00HUF
Average target price
12,931.29HUF
Spread / Average Target
+6.69%

Quarterly revenue - Rate of surprise